NRXP NRX Pharmaceuticals, Inc.

Fundamentals / CIK 0001719406 / USD
Other share classes on CIK 0001719406: NRXPW

NRX Pharmaceuticals, Inc. reported $4.31M in revenue and a net loss of $19.77M for the trailing twelve months ended September 30, 2026 (up 378.9% year over year), with a 40.0% gross margin and a -557.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NRXP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$11.03M$5.52M$0-$87.12MFY 2018 Net Income: $66K2018FY 2019 Net Income: $408K2019FY 2020 Net Income: -$51.78M2020FY 2021 Net Income: -$93.06M2021FY 2022 Net Income: -$39.75M2022FY 2023 Revenue: $0FY 2023 Net Income: -$30.15M2023FY 2024 Revenue: $0FY 2024 Net Income: -$25.13M2024FY 2025 Revenue: $1.23MFY 2025 Net Income: -$28.62M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.23M $0 $0 -- -- -- -- --
Cost of Revenue $505K $0 -- -- -- -- -- --
Gross Profit $720K $0 -- -- -- -- -- --
Research & Development $3.78M $6.20M $13.37M $17.03M $20.26M $10.62M -- --
Selling, General & Admin $13.06M $13.50M -- -- -- -- -- --
Total Operating Expenses -- $18.50M $27.84M $44.34M $115.8M $51.39M $713K $1.01M
Operating Income -$16.22M -$18.50M -$27.84M -$44.34M -$115.8M -$51.39M -$713K -$1.01M
EBITDA -$16.15M -$18.50M -$27.83M -$44.33M -$115.8M -$51.38M -- --
Interest Income $12K $44K $494K $249K -- -- -- --
Interest Expense $671K $230K $120K -- $18K $56K -- --
Income Before Tax -- -- -- -$39.75M -$93.06M -$51.78M $493K $82K
Income Tax Expense $0 $0 $0 -- -- $18K $84K $16K
Net Income -$28.62M -$25.13M -$30.15M -$39.75M -$93.06M -$51.78M $408K $66K
Basic EPS -$1.34 -$2.36 -$3.98 -$6.00 -$19.80 -$15.10 -$1.10 -$2.90
Diluted EPS -- -- -- -$6.00 -$19.80 -$15.10 -$1.10 -$2.90
Basic Shares Outstanding 21.4M 10.6M 7.6M 6.6M 4.7M 3.4M 278.3K 261.4K
Diluted Shares Outstanding -- -- -- 6.6M 4.7M 3.4M 278.3K 261.4K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $1.16M $1.10M $1.07M $983K $242K $0 $0 --
Cost of Revenue $874K $675K $631K $408K $97K $0 $0 --
Gross Profit $285K $426K $437K $575K $145K $0 $0 --
Research & Development $1.81M $2.12M $1.31M $558K $1.43M $987K $804K $1.04M
Selling, General & Admin $6.56M $4.75M $3.81M $4.57M $2.81M $2.74M $2.94M --
Total Operating Expenses -- -- -- -- -- $3.73M -- $2.43M
Operating Income -$8.14M -$6.50M -$4.74M -$4.62M -$4.02M -$3.73M -$3.85M -$2.43M
EBITDA -$8.08M -$6.43M -$4.68M -$4.58M -$4.00M -$3.73M -$3.85M -$3.42M
Interest Income $4.0K $6.0K $5.0K $4.0K $2.0K $2.0K $4.0K $4.0K
Interest Expense $239K $240K $233K $671K $0 $0 $0 $0
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$2.17M -$16.52M -$1.43M $360K -$5.89M -$17.58M -$5.51M -$9.08M
Basic EPS -$0.05 -$0.44 -$0.04 -- -$0.27 -$0.98 -$0.34 --
Basic Shares Outstanding 43.2M 37.6M 32.3M -- 22.2M 17.9M 16.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.80M $1.44M $4.59M $20.05M $27.61M $1.86M $877K $11K $449K
Cash & Short-Term Investments $7.80M $1.44M $4.59M $20.05M $27.61M $1.86M $877K $11K $449K
Accounts Receivable, Net $161K $0 -- -- -- $831K -- -- --
Other Current Assets -- -- -- -- -- $26K -- -- --
Total Current Assets $8.89M $3.30M $6.88M $25.80M $32.71M $2.93M $69K $30K $536K
Property, Plant & Equipment, Net $63K $10K -- -- -- -- -- -- --
Goodwill $1.79M $0 -- -- -- -- -- -- --
Intangible Assets $925K $0 -- -- -- -- -- -- --
Other Non-Current Assets $253K $339K $431K $21K $15K $11K -- -- --
Total Non-Current Assets $4.06M $349K $431K $21K $15K $11K $32.01M $70.77M $69.03M
Total Assets $12.96M $3.65M $7.32M $25.82M $32.73M $2.94M $32.07M $70.80M $69.57M
Accounts Payable $4.27M $4.13M $4.63M $2.08M $3.69M $3.15M -- -- --
Short-Term Debt -- -- $9.16M $7.70M -- -- -- -- --
Deferred Revenue (Current) -- -- -- -- $292K -- -- -- --
Total Current Liabilities $28.58M $21.86M $19.05M $15.59M $11.92M $46.16M $622K $567K $93K
Long-Term Debt -- -- $0 $2.82M -- -- -- -- --
Total Non-Current Liabilities $315K $5.01M $0 $2.82M $0 $548K $1.95M $690K $0
Total Liabilities $28.89M $26.87M $19.05M $18.41M $11.92M $46.71M $2.57M $1.26M $93K
Total Debt (incl. Leases) $631K -- $9.16M $10.53M -- -- -- -- --
Common Stock $32K $15K $8.0K $67K $59K $43K $2.8K $2.7K $2.6K
Retained Earnings -$306.9M -$278.3M -$253.1M -$223.0M -$183.2M -$90.18M $369K -$39K -$105K
Accumulated Other Comp. Income -- $0 -$3.0K -- -- -- -- -- --
Total Stockholders' Equity -$15.94M -$23.22M -$11.73M $7.41M $20.81M -$43.77M -$4.84M $5.00M $5.00M
Total Equity -$15.94M -$23.22M -$11.73M $7.41M $20.81M -$43.77M -$4.84M $5.00M $5.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $19.82M $26.69M $6.71M $7.80M $7.18M $2.91M $5.55M $1.44M
Cash & Short-Term Investments $19.82M $26.69M $6.71M $7.80M $7.18M $2.91M $5.55M $1.44M
Accounts Receivable, Net $218K $206K $181K $161K $239K -- -- $0
Total Current Assets $22.21M $29.16M $7.36M $8.89M $11.95M $4.59M $7.26M $3.30M
Property, Plant & Equipment, Net $901K $919K $259K $63K $69K -- -- $10K
Goodwill $2.35M $1.79M $1.79M $1.79M $610K -- -- $0
Intangible Assets $787K $832K $879K $925K $1.78M -- -- $0
Other Non-Current Assets $222K $224K $276K $253K $243K $248K $334K $339K
Total Non-Current Assets $5.61M $5.00M $4.54M $4.06M $3.05M $248K $334K $349K
Total Assets $27.82M $34.16M $11.90M $12.96M $15.00M $4.84M $7.59M $3.65M
Accounts Payable $4.11M $3.15M $4.40M $4.27M $4.26M $3.63M $4.31M $4.13M
Total Current Liabilities $29.25M $33.87M $25.18M $28.58M $40.59M $40.45M $32.75M $21.86M
Total Non-Current Liabilities $552K $456K $543K $315K $158K $0 $0 $5.01M
Total Liabilities $29.80M $34.33M $25.72M $28.89M $40.75M $40.45M $32.75M $26.87M
Total Debt (incl. Leases) $978K $834K $934K $631K $347K -- -- --
Common Stock $43K $43K $33K $32K $28K $19K $17K $15K
Retained Earnings -$327.0M -$324.8M -$308.3M -$306.9M -$307.3M -$301.4M -$283.8M -$278.3M
Accumulated Other Comp. Income -- -- -- -- -- -- -- $0
Total Stockholders' Equity -$1.99M -$170K -$13.82M -$15.94M -$25.75M -$35.62M -$25.16M -$23.22M
Total Equity -$1.99M -$170K -$13.82M -$15.94M -$25.75M -$35.62M -$25.16M -$23.22M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$28.62M -$25.13M -$30.15M -$39.75M -$93.06M -$51.78M $408K $66K
Depreciation & Amortization $70K $5.0K $5.0K $4.0K $2.0K $2.0K -- --
Stock-Based Compensation $228K $486K $387K $3.63M $7.79M $730K -- --
Change in Receivables $48K $0 -- -- $831K -$831K -- --
Change in Payables $113K -$5.22M $2.65M -$1.61M -$19K $1.18M -- --
Operating Cash Flow -$14.11M -$10.64M -$21.66M -$39.76M -$37.70M -$2.27M -$793K -$473K
Capital Expenditure -- $0 -$3.0K -$10K -$7.0K -$2.0K -- --
Free Cash Flow -- -$10.64M -$21.66M -$39.77M -$37.71M -$2.27M -- --
Acquisitions, Net -$2.38M $0 -- -- -- -- -- --
Purchases of Investments -$432K $0 -- -- -- -$283K -$993K -$690K
Investing Cash Flow -$2.81M $0 -$3.0K -$10K -$7.0K -$2.0K $40.25M -$647K
Common Stock Issued $6.39M $0 -- -- -- -$26.30M -$40.73M $0
Financing Cash Flow $23.28M $7.49M $6.20M $32.21M $63.46M $3.25M -$39.46M $682K
Net Change in Cash $6.35M -$3.15M -$15.46M -$7.55M $25.75M $982K -$11K -$438K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.17M -$16.52M -$1.43M $360K -$5.89M -$17.58M -$5.51M -$9.08M
Depreciation & Amortization $62K $71K $63K $42K $28K -$1.0K $1.0K -$990K
Stock-Based Compensation $188K $139K $151K $81K $68K $67K $12K $43K
Change in Receivables -$24K -$50K -$48K $36K $12K $0 $0 --
Change in Payables $964K -$1.25M $129K $13K $601K -$679K $178K -$10.17M
Operating Cash Flow -$6.71M -$8.88M -$4.29M -$3.71M -$2.89M -$4.03M -$3.48M -$2.10M
Capital Expenditure -- -- -- -- -- -- $0 $0
Free Cash Flow -- -- -- -- -- -- -$3.48M -$2.10M
Purchases of Investments -- -- -$213K -- -- -- $0 --
Investing Cash Flow $1.0K -$684K -$213K -$249K -$2.56M $0 $0 $0
Common Stock Issued -- -- $3.42M $1.64M $3.74M $1.01M $0 --
Financing Cash Flow -$152K $29.53M $3.42M $4.58M $9.73M $1.39M $7.58M $1.90M
Net Change in Cash -$6.86M $19.97M -$1.08M $613K $4.27M -$2.64M $4.11M -$203K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 58.8% -- -- -- -- -- -- --
Operating Margin -1324.4% -- -- -- -- -- -- --
Net Profit Margin -2336.5% -- -- -- -- -- -- --
Return on Equity (ROE) -- -- -- -536.6% -447.3% -- -- 1.3%
Return on Assets (ROA) -220.9% -688.2% -412.2% -154.0% -284.3% -1760.5% 1.3% 0.1%
Current Ratio 0.31x 0.15x 0.36x 1.66x 2.74x 0.06x 0.11x 0.05x
Quick Ratio 0.28x 0.07x 0.24x 1.29x 2.32x 0.06x 1.41x 0.02x
Debt to Equity -- -- -- 1.42x -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -12777.2% +517.9% --
5Y Net Income / Share Growth -- -260.8% -1674.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 40.0% 46.6% 50.5% 58.8% -- -- -- --
Operating Margin -557.1% -586.2% -746.6% -1324.5% -- -- -- --
Net Profit Margin -458.5% -691.8% -1070.3% -2336.6% -- -- -- --
Return on Assets (ROA) -71.1% -68.7% -206.2% -220.9% -253.8% -698.5% -317.7% -688.2%
Current Ratio 0.76x 0.86x 0.29x 0.31x 0.29x 0.11x 0.22x 0.15x
Quick Ratio 0.69x 0.79x 0.27x 0.28x 0.18x 0.07x 0.17x 0.07x
Revenue Growth (YoY) +378.9% -- -- -- -- -- -- --
Gross Profit Growth (YoY) +96.6% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001719406) · from December 31, 2017 Data through September 30, 2026 · synced Nov 20, 2026, 05:49 UTC · Open in terminal